Kirong, Baby Boy .
HRN: 23-05-41 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2023
AMPICILLIN 250MG (VIAL)
06/07/2023
06/13/2023
IVT
105mg
Q12hrs
Thickly MSAF, PROM X 16hrs
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes